Market Watch:
David Perlmutter, MD, FACN, ABIHM, internationally recognized for his expertise in the field of neurology, has joined the Scientific Advisory Board of LifeVantage Corporation.
Currently, Dr. Perlmutter is involved in pioneering work in the use of glutathione in fighting diseases such as Parkinson’s disease and Alzheimer’s. Dr. Perlmutter appeared on Oprah and Friends on April 3, 2009 with Dr. Oz to discuss new findings affecting Parkinson’s disease (www.oprah.com/oradio). Protandim(R) was proven to raise glutathione levels up to 300 percent, in a peer-reviewed study published in November 2008 in the Free Radical Biology and Medicine Journal.
Dr. Perlmutter commented, “The health benefits of increased glutathione are numerous, because of its antioxidant and potential anti-aging activity factors. Protandim’s(R) effects on glutathione enhancement are tremendous and as a neurologist, I am keenly interested in the impact of Protandim(R) on brain disorders as well as a variety of medical conditions and diseases. Working with LifeVantage provides me the ability to discuss the eloquence of the science supporting this product and its profound importance in human health.”
Logo from LifeVantage